Literature DB >> 2413066

Monoclonal human anti-DNA antibodies from EB virus-transformed lymphocytes of systemic lupus erythematosus (SLE) patients.

T Sasaki, T Muryoi, Y Sekiguchi, E Tamate, K Yoshinaga, Y Kitagawa.   

Abstract

Sixteen monoclonal human anti-DNA antibodies were obtained from Epstein-Barr virus-transformed lymphoblastoid cells of patients with systemic lupus erythematosus (SLE) and were studied in terms of antigenic specificity. All of the antibodies showed polyspecificity to polynucleotides. Among them, some antibodies had a specificity to single-stranded (ss) DNA. Especially, O-8 antibodies showed a preference for polynucleotides with pyrimidine bases. The binding specificity of the antibody was also studied using different sizes of dT oligomers in order to assess the size of the epitope. It was revealed that oligonucleotides with a size of more than 25-30 nucleotides are required for inhibition of the antibody to ss-DNA. Other studies also demonstrated that anti-ss-DNA (O-8) antibody and anti-double-stranded (ds) DNA (NE-28) antibody bound to different combining sites in the same polynucleotides, poly(dT). These results suggest that some anti-ss-DNA antibodies are directed to the conformational structure related to the base sequence and that nucleic acids, therefore, might be responsible for the possible immunogenic stimulus causing the anti-DNA immune response. We also indicate that this type of antibody would be popular among serum anti-DNA antibodies in SLE.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413066     DOI: 10.1007/bf00929459

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  PYRIMIDINE-SPECIFIC ANTIBODIES WHICH REACT WITH DEOXYRIBONUCLEIC ACID (DNA).

Authors:  S W Tanenbaum; S M Beiser
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

2.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

Authors:  E M Tan; P H Schur; R I Carr; H G Kunkel
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

3.  Establishment of human monoclonal anti-DNA antibody producing cell lines.

Authors:  T Sasaki; F Endo; M Mikami; Y Sekiguchi; K Tada; Y Ono; N Ishida; K Yoshinaga
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

4.  Multiple autoantigen binding capabilities of mouse monoclonal antibodies selected for rheumatoid factor activity.

Authors:  R L Rubin; R S Balderas; E M Tan; F J Dixon; A N Theofilopoulos
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

5.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

6.  Isolation of DNA from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus.

Authors:  H Sano; C Morimoto
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

7.  DNA-anti-DNA immune complexes. Antibody protection of a discrete DNA fragment from DNase digestion in vitro.

Authors:  W Emlen; R Ansari; G Burdick
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

8.  Structures for polyinosinic acid and polyguanylic acid.

Authors:  S Arnott; R Chandrasekaran; C M Marttila
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

9.  Induction of immunological tolerance to single-stranded and double-stranded DNA.

Authors:  T Sasaki; T Kadono; F Endo; S Ishida; K Yoshinaga
Journal:  Scand J Immunol       Date:  1982-09       Impact factor: 3.487

10.  Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease.

Authors:  D Koffler; R Carr; V Agnello; R Thoburn; H G Kunkel
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  11 in total

1.  Prevention of development of autoimmune disease in BXSB mice by mixed bone marrow transplantation.

Authors:  B Y Wang; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

2.  Epstein-Barr virus-transformed B cells bearing idiotypes of anti-DNA autoantibodies.

Authors:  O Takai; T Sasaki; T Muryoi; E Tamate; K Yoshinaga; H Sano
Journal:  J Clin Immunol       Date:  1988-05       Impact factor: 8.317

3.  Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.

Authors:  T Sasaki; S Shibata; Y Hirabayashi; Y Sekiguchi; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

4.  Incidence of anti-DNA idiotype-positive cells in human peripheral blood.

Authors:  O Takai; T Sasaki; T Muryoi; N Harata; H Hashimoto; K Yoshinaga
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

5.  Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.

Authors:  B Wang; Y Yamamoto; N S El-Badri; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Therapeutic treatment of New Zealand mouse disease by a limited number of anti-idiotypic antibodies conjugated with neocarzinostatin.

Authors:  N Harata; T Sasaki; H Osaki; T Saito; S Shibata; T Muryoi; O Takai; K Yoshinaga
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Binding specificity of antiidiotypic autoantibodies to anti-DNA antibodies in humans.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; H Saito; K Yoshinaga
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

8.  Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis.

Authors:  K Kinjoh; M Kyogoku; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin.

Authors:  T Sasaki; T Muryoi; O Takai; E Tamate; Y Ono; Y Koide; N Ishida; K Yoshinaga
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

10.  Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.

Authors:  T Muryoi; T Sasaki; N Harata; O Takai; E Tamate; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.